by Lawrence Mouawad | Mar 13, 2020 | In the News, Webinar
Dr. Ruben Mesa, Director, Mays Cancer Center, UT Health San Antonio, MD Anderson, offers guidance for patients with myeloproliferative neoplasms (MPNs) in dealing with the Coronavirus (Covid-19).
by Lawrence Mouawad | Feb 3, 2020 | In the News, Webinar
Dr. Ruben Mesa and Dr. Robyn Scherber hematologists from the Mays Cancer Center, home to UT Health San Antonio MD Anderson discuss the latest updates regarding new treatments for myeloproliferative neoplasms (MPNS) including essential thrombocythemia (ET),...
by Lawrence Mouawad | Jan 10, 2020 | In the News, Webinar
The MPN Advocates Network’s Giora Sharf interviews Dr. Ruben Mesa from the UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas about the biggest MPN updates we learned at ASH 2019.
by Lawrence Mouawad | Aug 21, 2019 | In the News, Webinar
“BREAKING NEWS: The FDA has approved fedratinib as a new treatment option for myelofibrosis patients. Watch now as our Editorial and Community Director, Rebecca Seago-Coyle, sits down with Dr. Ruben Mesa, Director of Mays Cancer Center at UT Health San Antonio...
In the News